These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32651994)

  • 1. Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study.
    Li YF; Zhang QQ; Wang WL
    Med Sci Monit; 2020 Jul; 26():e923375. PubMed ID: 32651994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
    Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
    World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of small-cell versus large-cell gastroenteropancreatic neuroendocrine carcinomas: A population-based study.
    Abdel-Rahman O; Fazio N
    J Neuroendocrinol; 2021 May; 33(5):e12971. PubMed ID: 33870570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
    Lv Y; Han X; Xu XF; Ji Y; Zhou YH; Sun HC; Zhou J; Fan J; Lou WH; Huang C
    BMC Cancer; 2019 Apr; 19(1):335. PubMed ID: 30961559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.
    Yi Z; Liu R; Hu J; He T; Wang Z; Li Y; Zu X
    Clin Genitourin Cancer; 2021 Apr; 19(2):155-161. PubMed ID: 33288452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis.
    Li J; Lin Y; Wang Y; Lin H; Lin F; Zhuang Q; Lin X; Wu J
    ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32253246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort.
    Lithgow K; Venkataraman H; Hughes S; Shah H; Kemp-Blake J; Vickrage S; Smith S; Humphries S; Elshafie M; Taniere P; Diaz-Cano S; Dasari BVM; Almond M; Ford S; Ayuk J; Shetty S; Shah T; Geh I
    Sci Rep; 2021 Sep; 11(1):17947. PubMed ID: 34504148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients.
    Baeg K; Harris C; Naparst MS; Ahn E; Thapi S; Martin J; Rustgi S; Mhango G; Wisnivesky J; Kim MK
    BMC Cancer; 2021 Feb; 21(1):146. PubMed ID: 33563241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
    Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
    Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
    Xu B; Chu Y; Hu Q; Song Q
    Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
    Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
    Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients: A population based analysis.
    Wang S; Zhang J; Liu S; Zhang J
    Medicine (Baltimore); 2019 Nov; 98(44):e17773. PubMed ID: 31689842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
    Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
    BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Zhou H; Zhang Y; Song Y; Tan W; Qiu Z; Li S; Chen Q; Gao S
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):476-486. PubMed ID: 28416359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
    Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.